We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$155M
AUM Growth
-$60.5M
Cap. Flow
+$5.8M
Cap. Flow %
3.73%
Top 10 Hldgs %
75.53%
Holding
36
New
–
Increased
3
Reduced
3
Closed
1

Top Buys

Rank Stock Value
1
ENTX icon
Entera Bio
ENTX
+$3.73M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.87M
3
APLT
Applied Therapeutics
APLT
+$1.41M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$912K
2
HOOK
HOOKIPA Pharma
HOOK
+$164K
3
IRD
Opus Genetics
IRD
+$115K

Sector Composition

Rank Sector Weight
1 Healthcare 71.85%
2 Materials 16.98%
3 Industrials 1.73%
4 Consumer Staples 1.33%
5 Financials 0.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28.4M 18.28%
760,422
+50,000
+7% +$1.87M
ALDX icon
2
Aldeyra Therapeutics
ALDX
$91.7M
$27.3M 17.59%
5,475,516
– –
ENTX icon
3
Entera Bio
ENTX
$101M
$12.5M 8.03%
5,881,879
+2,000,000
+52% +$3.73M
VRNA
4
DELISTED
Verona Pharma
VRNA
$9.29M 5.98%
200,000
– –
ALT icon
5
Altimmune
ALT
$539M
$8.09M 5.21%
1,121,524
– –
GLD icon
6
SPDR Gold Trust
GLD
$131B
$7.75M 4.99%
32,000
– –
MGTX icon
7
MeiraGTx Holdings
MGTX
$1.09B
$7.61M 4.9%
1,250,000
– –
AVDL
8
DELISTED
Avadel Pharmaceuticals
AVDL
$6.31M 4.06%
600,000
– –
OCUL icon
9
Ocular Therapeutix
OCUL
$1.86B
$5.13M 3.3%
600,400
– –
APLT
10
DELISTED
Applied Therapeutics
APLT
$4.96M 3.2%
5,799,687
+225,000
+4% +$1.41M
AEM icon
11
Agnico Eagle Mines
AEM
$72.6B
$4.34M 2.79%
55,500
– –
KGC icon
12
Kinross Gold
KGC
$28.5B
$4.08M 2.63%
440,000
– –
SA
13
Seabridge Gold
SA
$2.8B
$3.62M 2.33%
317,003
– –
FNV icon
14
Franco-Nevada
FNV
$41.4B
$2.94M 1.89%
25,000
– –
EQX icon
15
Equinox Gold
EQX
$7.32B
$2.77M 1.78%
550,811
– –
SKE
16
Skeena Resources
SKE
$3.36B
$2.75M 1.77%
315,400
– –
MAG
17
DELISTED
MAG Silver
MAG
$2.31M 1.49%
170,000
– –
SLV icon
18
iShares Silver Trust
SLV
$28.1B
$2.11M 1.36%
80,000
– –
BAH icon
19
Booz Allen Hamilton
BAH
$8.7B
$1.67M 1.08%
13,000
– –
V icon
20
Visa
V
$677B
$1.53M 0.99%
4,850
– –
PM icon
21
Philip Morris
PM
$301B
$1.2M 0.77%
10,000
– –
ITA icon
22
iShares US Aerospace & Defense ETF
ITA
$14.2B
$1.11M 0.72%
7,650
– –
NOC icon
23
Northrop Grumman
NOC
$77B
$1.02M 0.65%
2,165
– –
HOOK
24
DELISTED
HOOKIPA Pharma
HOOK
$1M 0.65%
498,625
-53,113
-10% -$164K
RGLD icon
25
Royal Gold
RGLD
$17.1B
$995K 0.64%
7,550
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Knoll Capital Management held 36 positions worth $155M, down 28% from $216M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Knoll Capital Management deployed $5.8M of net new capital in Q4 2024, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, down from 74% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was HOOKIPA Pharma, an estimated $164K trimmed.

  • Knoll Capital Management added most to Entera Bio in Q4 2024, an estimated $3.73M increase.
  • Knoll Capital Management's biggest Q4 2024 reduction was HOOKIPA Pharma, cutting an estimated $164K.
  • Knoll Capital Management fully exited CVS Health in Q4 2024, selling an estimated $912K.
  • Knoll Capital Management's ten largest holdings make up 76% of its $155M portfolio in Q4 2024.
  • Knoll Capital Management opened 0 new positions and closed 1 in Q4 2024.
  • Knoll Capital Management's portfolio value fell 28% quarter-over-quarter to $155M.

Based on Knoll Capital Management's 13F filing for Q4 2024, filed 18 Feb 2025.